Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review
Alessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100354-100354
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians
Demetrios Moris, Manisha Palta, Charles Kim, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 73, Iss. 2, pp. 198-222
Open Access | Times Cited: 260
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
Domenico Alvaro, Gregory J. Gores, Joël Walicki, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 181-208
Open Access | Times Cited: 126
A review of F-18 fluorodeoxyglucose PET/CT in the evaluation and treatment of hepatobiliary tumors
Bradley J. Girod, Asha Kandathil
The Quarterly Journal of Nuclear Medicine and Molecular Imaging (2025) Vol. 68, Iss. 4
Closed Access | Times Cited: 1
Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma
Andrea Lauterio, Riccardo De Carlis, Leonardo Centonze, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3657-3657
Open Access | Times Cited: 71
Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies
Justin H. Lo, Rajiv Agarwal, Laura W. Goff, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3312-3312
Open Access | Times Cited: 24
New trends in diagnosis and management of gallbladder carcinoma
Efstathios Pavlidis, I. Galanis, T. Pavlidis
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 1, pp. 13-29
Open Access | Times Cited: 11
Current progress in perioperative chemotherapy for biliary tract cancer
Tatsuya Ioka, Yoshitaro Shindo, Makoto Ueno, et al.
Annals of Gastroenterological Surgery (2023) Vol. 7, Iss. 4, pp. 565-571
Open Access | Times Cited: 16
Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma
Margaret Wheless, Rajiv Agarwal, Laura W. Goff, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 1, pp. 127-160
Open Access | Times Cited: 7
Immune checkpoint inhibitors in gastrointestinal malignancies: an Umbrella review
Maryam Noori, Farideh Jafari‐Raddani, Zeinab Davoodi‐Moghaddam, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Advances in Immunotherapy for Transplant Oncology
Maen Abdelrahim, Abdullah Esmail, Aiwu Ruth He, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2369-2369
Open Access | Times Cited: 7
Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy
Yanjun Sun, Jun-feng Gong, Zhuang Li, et al.
Postgraduate Medicine (2024) Vol. 136, Iss. 3, pp. 278-291
Closed Access | Times Cited: 6
Changing Landscape of Systemic Therapy in Biliary Tract Cancer
Edward Woods, Dat Tan Le, Bharath Kumar Jakka, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2137-2137
Open Access | Times Cited: 24
Liver transplantation as an alternative for the treatment of perihilar cholangiocarcinoma: A critical review
Wellington Andraus, Francisco Tustumi, Alexandre Chagas Santana, et al.
Hepatobiliary & pancreatic diseases international (2024) Vol. 23, Iss. 2, pp. 139-145
Closed Access | Times Cited: 4
The Clinical Association Between the Inflammation-Nutritional Condition and Prognosis of Locally Advanced Intrahepatic Cholangiocarcinoma After R0 Resection: Evidence from Competing Risk and Propensity Matching Analysis
G. Huang, Pu Xi, Zehui Yao, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 2787-2799
Open Access | Times Cited: 4
Neoadjuvant therapy reduces node positivity but does not confer survival benefit versus up‐front resection for resectable intrahepatic cholangiocarcinoma: A propensity‐matched analysis
Chase J. Wehrle, Jenny H. Chang, Kimberly Woo, et al.
Journal of Surgical Oncology (2024) Vol. 130, Iss. 3, pp. 453-461
Open Access | Times Cited: 4
Prognostic factors and preoperative therapy in resectable intrahepatic cholangiocarcinoma
A. N. Polyakov, Yu. I. Patyutko, Д. А. Гранов, et al.
Pirogov Russian Journal of Surgery (2025), Iss. 1, pp. 5-5
Closed Access
Protocolo diagnóstico y terapéutico del carcinoma de la vía biliar
R. Molina Villaverde, B. Martínez-Amores, A. López Alfonso, et al.
Medicine - Programa de Formación Médica Continuada Acreditado (2025) Vol. 14, Iss. 25, pp. 1501-1505
Closed Access
Artificial intelligence for automatic diagnosis and pleomorphic morphological characterization of malignant biliary strictures using digital cholangioscopy
Miguel Mascarenhas, Maria João Almeida, Mariano González-Haba, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Optimizing Circulating Tumour DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma: Diagnosis, Screening, Minimal Residual Disease Detection and Treatment Response Monitoring
Woo Jin Choi, Tommy Ivanics, Annabel Gravely, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 6, pp. 3849-3863
Closed Access | Times Cited: 11
Neoadjuvant Therapy for Extrahepatic Biliary Tract Cancer: A Propensity Score-Matched Survival Analysis
Junya Toyoda, Kota Sahara, T Takahashi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2654-2654
Open Access | Times Cited: 11
An overview of extrahepatic cholangiocarcinoma: from here to where?
Yongheng Yang, Xiaolu Zhang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
Matteo Renzulli, Daryl Ramai, Jameel Singh, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3336-3336
Open Access | Times Cited: 23
Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
Timo Alexander Auer, Federico Collettini, Laura Segger, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2655-2655
Open Access | Times Cited: 9
Removal of intrahepatic bile duct stone could reduce the risk of cholangiocarcinoma: A single-center retrospective study in South Korea
Tae In Kim, Sung Yong Han, Jonghyun Lee, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 5, pp. 913-921
Open Access | Times Cited: 3
Fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma: current status, insight on resistance mechanisms and toxicity management
Sakti Chakrabarti, Heidi D. Finnes, Amit Mahipal
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 1, pp. 85-98
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top